SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (142)4/8/1999 9:14:00 AM
From: scaram(o)uche  Respond to of 52153
 
Let's use this phrase frequently, on several threads. No need to use it on the GILD, MLNM or NXTR threads.........

"Caught in the headlights"

I was asked in another thread (?) if I would feel cheated if one of my potential 10-baggers was taken out at 3X. To answer..... I would not mind seeing MLNM take out SIBI at *1*X. I would not mind seeing MLNM take out BTRN at *1*X. I believe that it would pay in the future. I would much prefer this to Merck or Novartis, respectively, at 3X.

Where are you, biotech CEOs? What are you doing? Are you just securing the hatches and waiting?



To: LLCF who wrote (142)4/8/1999 2:34:00 PM
From: CPAMarty  Read Replies (1) | Respond to of 52153
 
the best place to find a list of the numerous clinical trials that IMCL has going is imclone.com

C225 has a relatively short trial period, which could be made shorter by FDA fast track approval

about a month ago there was a great discussion going on at yahoo
messages.yahoo.com

IMCL will be presenting at a conference shortly
Message 8544439